GI
BHC icon

Gradient Investments’s Bausch Health BHC Stock Holding History

Gradient Investments’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-3,898
Closed -$492K – 488
2014
Q2 		$492K Buy
3,898
+574
+17% +$73.2K 0.1% 130
2014
Q1 		$438K Buy
+3,324
New +$454K 0.1% 133

Other funds holding BHC

RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
VH
ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Gradient Investments's BHC Position: Q3 2014 in Review

Gradient Investments sold out of Bausch Health (BHC) in Q3 2014, closing a stake of 3,898 shares — an estimated $492K sold.

Gradient Investments first reported a position in BHC in Q1 2014 and held it in 2 quarters. The position peaked at $492K in Q2 2014. 454 funds tracked by Wall St. Rank hold BHC as of Q3 2014.

  • Gradient Investments reported no remaining Bausch Health position as of Q3 2014 after selling out during the quarter.
  • Gradient Investments sold 3,898 Bausch Health shares in Q3 2014, an estimated $492K.
  • Gradient Investments first reported a position in Bausch Health in Q1 2014 and held it in 2 quarters.
  • Gradient Investments's Bausch Health position peaked at $492K in Q2 2014.
  • 454 funds tracked by Wall St. Rank held Bausch Health as of Q3 2014.

Based on Gradient Investments's 13F filing for Q3 2014, filed 14 Oct 2014.